Status of peripheral sodium channel blockers for non-addictive pain treatment

M Alsaloum, GP Higerd, PR Effraim… - Nature Reviews …, 2020 - nature.com
The effective and safe treatment of pain is an unmet health-care need. Current medications
used for pain management are often only partially effective, carry dose-limiting adverse …

Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief

EC Emery, AP Luiz, JN Wood - Expert opinion on therapeutic …, 2016 - Taylor & Francis
Introduction: Chronic pain is a massive clinical problem. We discuss the potential of subtype
selective sodium channel blockers that may provide analgesia with limited side effects …

Voltage gated sodium channels as drug discovery targets

SK Bagal, BE Marron, RM Owen, RI Storer, NA Swain - Channels, 2015 - Taylor & Francis
Voltage-gated sodium (NaV) channels are a family of transmembrane ion channel proteins.
They function by forming a gated, water-filled pore to help establish and control cell …

Voltage-gated ion channels in the PNS: novel therapies for neuropathic pain?

GR Tibbs, DJ Posson, PA Goldstein - Trends in pharmacological sciences, 2016 - cell.com
Neuropathic pain arises from injury to the nervous system. Conditions associated with
neuropathic pain are diverse, and lesions and/or pathological changes in the central …

Voltage gated sodium channel inhibitors as anticonvulsant drugs: A systematic review on recent developments and structure activity relationship studies

R Pal, B Kumar, MJ Akhtar, PA Chawla - Bioorganic Chemistry, 2021 - Elsevier
Voltage-gated sodium channel blockers are one of the vital targets for the management of
several central nervous system diseases, including epilepsy, chronic pain, psychiatric …

Managing neuropathic pain in dogs

SA Moore - Frontiers in veterinary science, 2016 - frontiersin.org
Disorders of the somatosensory system such as neuropathic pain are common in people
with chronic neurologic and musculoskeletal diseases, yet these conditions remain an …

Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7

JV Mulcahy, H Pajouhesh, JT Beckley… - Journal of medicinal …, 2019 - ACS Publications
Voltage-gated sodium ion channel subtype 1.7 (NaV1. 7) is a high interest target for the
discovery of non-opioid analgesics. Compelling evidence from human genetic data …

Voltage-gated sodium channels: structures, functions, and molecular modeling

L Xu, X Ding, T Wang, S Mou, H Sun, T Hou - Drug discovery today, 2019 - Elsevier
Highlights•The structures and functions of VGSCs are briefly outlined.•The major binding
sites and isoform-selective modulators of VGSCs are summarized.•The studies on the …

Discovery of allosteric, potent, subtype selective, and peripherally restricted TrkA kinase inhibitors

SK Bagal, K Omoto, DC Blakemore… - Journal of medicinal …, 2018 - ACS Publications
Tropomyosin receptor kinases (TrkA, TrkB, TrkC) are activated by hormones of the
neurotrophin family: nerve growth factor (NGF), brain derived neurotrophic factor (BDNF) …

Disordered breathing in a Pitt-Hopkins syndrome model involves Phox2b-expressing parafacial neurons and aberrant Nav1. 8 expression

CM Cleary, S James, BJ Maher, DK Mulkey - Nature communications, 2021 - nature.com
Pitt-Hopkins syndrome (PTHS) is a rare autism spectrum-like disorder characterized by
intellectual disability, developmental delays, and breathing problems involving episodes of …